Fosdevirine
Clinical data | |
---|---|
Other names | GSK2248761; GSK2248761A; IDX-12899; IDX-899 |
ATC code |
|
Identifiers | |
| |
JSmol) | |
| |
|
Fosdevirine is an experimental antiviral agent of the
It was discovered by Idenix Pharmaceuticals and was being developed by
GlaxoSmithKline and ViiV Healthcare, but it has now been discontinued[3][4] due to unexpected side effects.[5]
References
- PMID 26804933.
- ^ "Fosdevirine". AIDSinfo. U.S. National Library of Medicine, U.S. Department of Health and Human Services. Archived from the original on 2019-08-11. Retrieved 2018-08-14.
- ^ "Fosdevirine". Adis Insight. Springer Nature Switzerland AG.
Highest Development Phases: Discontinued, HIV-1 infections
- ^ "Fosdevirine". MedKoo Biosciences.
GSK2248761 is no longer in clinical development.
- S2CID 6147197.